/Companies

Immuron

NASDAQ: IMRN

2 known investors

Find your way into Immuron

Sign up to see every warm intro you have to Immuron

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Immuron team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Immuron is an Australian biopharmaceutical company developing and commercialising targeted polyclonal antibodies aimed at addressing unmet medical needs. Its products, based on a patented technology platform, are formulated to reduce diarrhoea, support gastrointestinal and digestive health, and promote immune defence.

Founders & leadership

SL
Steven Lydeamore

Investors · 2

Frequently asked questions

What does Immuron do?
Immuron is an Australian biopharmaceutical company developing and commercialising targeted polyclonal antibodies aimed at addressing unmet medical needs. Its products, based on a patented technology platform, are formulated to reduce diarrhoea, support gastrointestinal and digestive health, and promote immune defence.
Who are Immuron's investors?
Immuron's investors include Silver Lake Partners, venBio Partners.